Product Information
NEURONTIN 800 MG TABLET is a brand product labeled by Pfizer Inc., priced at $16.9777 per EA under NDC 00071040124. Its NADAC has been published 535 times since Nov 28, 2013.
FDA first approved this application on Oct 9, 1998. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
Pfizer Inc.NDC
00071040124
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA020882FDA Approved
10/9/1998
TE Code
AB1
On Market Since
10/9/1998
Pharmacological Classes
Price Statistics
The NADAC for NEURONTIN 800 MG TABLET has been published 535 times since Nov 28, 2013, and over the history we have for it it has risen 208.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.9777 per EA |
|---|---|
| All-time high | $16.9777 (Aug 19, 2026) |
| All-time low | $5.5100 (Nov 28, 2013) |
| 52-week high | $16.9777 |
| 52-week low | $16.0658 |
| Median price | $12.2415 |
| Average price | $11.4278 |
| Largest weekly change | +17.5% (Jul 17, 2024) |
| Weeks tracked | 535 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEURONTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEURONTIN 800 MG TABLET, manufactured by Pfizer Inc., is $16.9777 per EA (NDC 00071040124), effective Aug 19, 2026.
How has the price of NEURONTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEURONTIN 800 MG TABLET has risen 208.1%. It has been tracked across 535 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEURONTIN 800 MG TABLET?
Since Nov 28, 2013, the NADAC for NEURONTIN 800 MG TABLET has ranged from a low of $5.5100 (Nov 28, 2013) to a high of $16.9777 (Aug 19, 2026), with a median of $12.2415 per EA.
Are there cheaper alternatives to NEURONTIN 800 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0900 per EA — about 99% below NEURONTIN 800 MG TABLET.
Who manufactures NEURONTIN 800 MG TABLET?
NEURONTIN 800 MG TABLET (NDC 00071040124) is labeled by Pfizer Inc., and CMS classifies it as a brand product.